retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial The TRIUMPH-1 3 results just dropped on retatrutide. Here is what the numbers actually say. is a agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro retatrutide triple agonist glp-1 gip

Stay hydrated while trying to conceive, throughout pregnancy and beyond

Enter Cagrilintide, a long-acting amylin analog peptide developed by Novo Nordisk

Cagrilintide shows greater potency and a longer half-life (approximately 7 days) than earlier amylin analogs like Pramlintide, which is why its generating attention in the metabolic optimization space

- Applying Niacinamide immediately may reduce peel efficacy and cause sensitivity

While research on neurodegenerative diseases has advanced significantly, with increasing insights from cell lines and murine animal models highlighting the bidirectional link between energy metabolism and brain inflammatory responses, the specificity of human specimens is limited to postmortem brain tissues

Association of maternal age with adverse pregnancy outcomes: A prospective multicenter cohort study in China